- Home
- AMWD vs NEO Comparison
AMWD vs NEO Comparison
Compare AMWD & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMWD
- NEO
- Stock Information
- Founded
- AMWD 1980
- NEO 2001
- Country
- AMWD United States
- NEO United States
- Employees
- AMWD N/A
- NEO N/A
- Industry
- AMWD Forest Products
- NEO Precision Instruments
- Sector
- AMWD Basic Materials
- NEO Health Care
- Exchange
- AMWD Nasdaq
- NEO Nasdaq
- Market Cap
- AMWD 940.7M
- NEO 1.0B
- IPO Year
- AMWD N/A
- NEO 1999
- Fundamental
- Price
- AMWD $67.61
- NEO $8.11
- Analyst Decision
- AMWD Buy
- NEO Buy
- Analyst Count
- AMWD 3
- NEO 10
- Target Price
- AMWD $70.00
- NEO $12.56
- AVG Volume (30 Days)
- AMWD 189.7K
- NEO 2.9M
- Earning Date
- AMWD 08-26-2025
- NEO 11-04-2025
- Dividend Yield
- AMWD N/A
- NEO N/A
- EPS Growth
- AMWD N/A
- NEO N/A
- EPS
- AMWD 5.62
- NEO N/A
- Revenue
- AMWD $1,653,503,000.00
- NEO $689,189,000.00
- Revenue This Year
- AMWD N/A
- NEO $10.40
- Revenue Next Year
- AMWD $4.06
- NEO $10.11
- P/E Ratio
- AMWD $12.03
- NEO N/A
- Revenue Growth
- AMWD N/A
- NEO 9.70
- 52 Week Low
- AMWD $50.00
- NEO $4.72
- 52 Week High
- AMWD $104.28
- NEO $19.12
- Technical
- Relative Strength Index (RSI)
- AMWD 56.89
- NEO 59.85
- Support Level
- AMWD $64.25
- NEO $7.60
- Resistance Level
- AMWD $70.07
- NEO $8.42
- Average True Range (ATR)
- AMWD 2.38
- NEO 0.49
- MACD
- AMWD -0.06
- NEO -0.00
- Stochastic Oscillator
- AMWD 51.62
- NEO 54.98
About AMWD American Woodmark Corporation
American Woodmark Corp manufactures and distributes cabinets and vanities for the remodeling and new home construction markets. It offers several products that fall into product lines including kitchen cabinetry, bath cabinetry, office cabinetry, home organization, and hardware. The products are sold under the brand names American Woodmark, Timberlake, Shenandoah Cabinetry, and Waypoint Living Spaces among others.
About NEO NeoGenomics Inc.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.